ES2129146T3 - Compuestos citratos alcalino-calcicos y su utilizacion como medicamentos. - Google Patents

Compuestos citratos alcalino-calcicos y su utilizacion como medicamentos.

Info

Publication number
ES2129146T3
ES2129146T3 ES95104030T ES95104030T ES2129146T3 ES 2129146 T3 ES2129146 T3 ES 2129146T3 ES 95104030 T ES95104030 T ES 95104030T ES 95104030 T ES95104030 T ES 95104030T ES 2129146 T3 ES2129146 T3 ES 2129146T3
Authority
ES
Spain
Prior art keywords
medicines
alkaline
calcium citrate
citrate compounds
alkali metal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95104030T
Other languages
English (en)
Inventor
Alfons Dr Rer Nat Carcasona
Klaus Prof Dr Rer Reinhardt
Paul-Otto Prof Dr Rer Schwille
Wilfried Dr Rer Nat Wachter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Madaus Holding GmbH
Original Assignee
Madaus AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19944409949 external-priority patent/DE4409949C2/de
Priority claimed from DE19944409948 external-priority patent/DE4409948A1/de
Application filed by Madaus AG filed Critical Madaus AG
Application granted granted Critical
Publication of ES2129146T3 publication Critical patent/ES2129146T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265—Citric acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA INVENCION SE REFIERE A LA ELABORACION DE COMPUESTOS DE CITRATO ALCALINO - CALCIO Y LA UTILIZACION DE AL MENOS UN COMPUESTO DE CITRATO METAL ALCALINO - CALCIO DE LA FORMULA GENERAL CAXC6H5O7, DONDE X ES UN METAL ALCALINO O UNO DE SUS HIDRATOS O MEZCLA DE HIDRATOS, ASI COMO A LA CONSTITUCION DE PROTEINAS MUSCULARES Y A LA ELEVACION DE LA POTENCIA DE CAMBIO DE SUSTANCIA MUSCULAR MEDIANTE ACCION ANTICATABOLICA, ASI COMO TAMBIEN RECONVALESCENCIA Y TRATAMIENTO PALIATIVO EN SITUACIONES DE CAMBIO DE SUSTANCIA CATABOLICA O ENFERMEDADES DEGENERATIVAS, ASI COMO PARA LA PROFILAXIS O TRATAMIENTO DE DESAPARICION DE TEJIDOS DE HUESOS Y PARA EL REFORZAMIENTO DE LOS ELEMENTOS DE ESTRUCTURA DE HUESOS.
ES95104030T 1994-03-23 1995-03-18 Compuestos citratos alcalino-calcicos y su utilizacion como medicamentos. Expired - Lifetime ES2129146T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19944409949 DE4409949C2 (de) 1994-03-23 1994-03-23 Verwendung von Calcium-Alkalicitraten zur Prophylaxe und Behandlung degenerativer Erkrankungen des Knochengerüstes
DE19944409948 DE4409948A1 (de) 1994-03-23 1994-03-23 Calcium-Alkalicitratverbindungen und deren Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
ES2129146T3 true ES2129146T3 (es) 1999-06-01

Family

ID=25934979

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95104030T Expired - Lifetime ES2129146T3 (es) 1994-03-23 1995-03-18 Compuestos citratos alcalino-calcicos y su utilizacion como medicamentos.

Country Status (6)

Country Link
EP (1) EP0673913B1 (es)
JP (2) JP2948122B2 (es)
AT (1) ATE176662T1 (es)
DE (1) DE59505063D1 (es)
DK (1) DK0673913T3 (es)
ES (1) ES2129146T3 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6287607B2 (en) * 1999-07-19 2001-09-11 Mission Pharmacal Company Potassium calcium citrate compositions and methods therefor
DE102005040423A1 (de) * 2005-08-25 2007-03-01 Lahrsow, Jobst, Dr. med. dent. Nahrungsmittelzusatz zur Versorgung mit Mineralstoffen
EP2389078A4 (en) * 2009-01-22 2012-10-31 Mission Pharma Co DOUBLE CATION AND DOUBLE ANION COORDINATION COMPLEXES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2727304C2 (de) * 1977-06-16 1982-12-02 Dr. Madaus & Co, 5000 Köln Saures Alkalicitrat, dessen Herstellung und Verwendung

Also Published As

Publication number Publication date
EP0673913B1 (de) 1999-02-10
JPH11255642A (ja) 1999-09-21
EP0673913A1 (de) 1995-09-27
DE59505063D1 (de) 1999-03-25
DK0673913T3 (da) 1999-09-20
ATE176662T1 (de) 1999-02-15
JP2948122B2 (ja) 1999-09-13
JPH0840975A (ja) 1996-02-13

Similar Documents

Publication Publication Date Title
MX9102407A (es) 4 arilpiperazinas y 4-arilpiperidinas novedosas.
DE59709414D1 (de) Oxyiminopregnancarbolactone
ES2058614T3 (es) 1,2-ciclohexilaminoarilaminadas utiles como agentes analgesicos.
DE59510421D1 (de) Substituierte Pyridylpyrazole
ES2154266T3 (es) Amidas de acido sulfonamidocarbonilpiridin-2-carboxilico y su empleo como medicamentos.
DK0409435T3 (da) Heteroarylpiperaziner som antipsykotiske midler
ES515033A0 (es) "proceso para la produccion microbiana de interferon fibroblasto humano".
DK314487D0 (da) Benzoxepinderivat
IL80114A0 (en) Quinoline derivatives,their manufacture and pharmaceutical compositions containing them
CZ282732B6 (cs) Substituované 1,2,3,4-tetrahydrocyklopent/b/indoly, 1,2,3,3a,4,8a-hexahydrocyklopent/b/indoly a příbuzné sloučeniny, meziprodukty a způsob jejich přípravy a jejich použití jako léčiv
ES2060127T3 (es) Halogenoalquilfenil-alcoholes-cetonas y sus hidratos.
DK516684D0 (da) Purinderivater
DK0406745T3 (da) Antibiotiske GE 2270 faktorer A1, A2, A3 og H
FI863565A0 (fi) Foerfarande foer framstaellning av nya pyrrobenzimidazoler, pyrrolbenzoxazoler och pyrrolbenztiazoler.
ES2129146T3 (es) Compuestos citratos alcalino-calcicos y su utilizacion como medicamentos.
DK0451486T3 (da) Antibiotikum GE 2270 faktorer B1, B2, C1, C2, D1, D2, E og T
DE3872425D1 (de) Substituierte tetrahydroisochinolin-verbindungen, ihre herstellung und diese enthaltende pharmazeutische mittel.
LV10870A (lv) Jauni fosfolipidu atvasinajumi
CY1106882T1 (el) Τροποποιηση βητακυτταρουλινης
SE8500822D0 (sv) Diazepinoindoles, their production and pharmaceutical compositions containing them
IT1241927B (it) 3'-deamino-4'-deossi-4'-amino-8-fluoroantra- cicline processi per la loro preparazione e composizioni farmaceutiche che le contengono
DK0677513T3 (da) Octahydro-2-naphthalencarboxylsyrederivat, dets fremstilling og anvendelse
DE59003446D1 (de) 13-Brom und 13, 14-Dibrom-Ergoline, ihre Herstellung und Verwendung in Arzneimitteln.
DE69204733D1 (de) Antibiotikverbindungen und ihre Herstellung.
DE69907671D1 (en) Hydroxyphenylsulfanylbenzoesäure- und -arylessigsäure-derivate

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 673913

Country of ref document: ES